HF
AUTL icon

HRT Financial’s Autolus Therapeutics AUTL Stock Holding History

HRT Financial’s Portfolio AUTL Stock Details AUTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$142K Buy
+89,363
New +$140K ﹤0.01% 3514
2025
Q4 		– Sell
-210,172
Closed -$342K – 3165
2025
Q3 		$342K Buy
+210,172
New +$411K ﹤0.01% 2096
2021
Q3 		– Sell
-34,303
Closed -$227K – 3264
2021
Q2 		$227K Buy
34,303
+23,417
+215% +$145K ﹤0.01% 2313
2021
Q1 		$62K Buy
+10,886
New +$80.6K ﹤0.01% 2521

Other funds holding AUTL

MCO
MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $39B AUM 18.55% 1-Year Est. Return
SP
Syncona Portfolio St Peter Port, Guernsey $26.6M AUM 10.36% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
TAM
TFG Asset Management Grand Cayman, Cayman Islands $635M AUM 28.07% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

HRT Financial's AUTL Position: Q2 2026 in Review

HRT Financial opened a new position in Autolus Therapeutics (AUTL) in Q2 2026: 89,363 shares worth $142K. The stake represents ﹤0.01% of the portfolio and ranks #3514 among its holdings. This is a return to the name: HRT Financial previously reported a position in AUTL as recently as Q3 2025.

HRT Financial first reported a position in AUTL in Q1 2021 and has held it in 4 quarters since. The position peaked at $342K in Q3 2025. 83 funds tracked by Wall St. Rank hold AUTL as of Q2 2026.

  • HRT Financial held 89,363 shares of Autolus Therapeutics worth $142K as of Q2 2026.
  • Autolus Therapeutics was a new HRT Financial position in Q2 2026.
  • Autolus Therapeutics made up ﹤0.01% of HRT Financial's portfolio in Q2 2026, its #3514 holding.
  • HRT Financial first reported a position in Autolus Therapeutics in Q1 2021 and has held it in 4 quarters since.
  • HRT Financial's Autolus Therapeutics position peaked at $342K in Q3 2025.
  • 83 funds tracked by Wall St. Rank held Autolus Therapeutics as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.